4527 Rohto Pharmaceutical
- 3476.0
- -14.0-0.40%
Rohto Pharmaceutical News
Rohto Pharmaceutical: Interim report
Rohto Pharmaceutical: Confirmation letter
Rohto Pharmaceutical: Securities Report - 88th period (April 1, 2023 - March 31, 2024)
Rohto Pharmaceutical: Extraordinary Report
Rohto Pharmaceutical: Rohto Pharmaceutical Co., Ltd. 88th term (2023) reference materials
Rohto Pharmaceutical: Financial results briefing for the fiscal year ending March 2024
Rohto Pharmaceutical: Summary of financial results for the fiscal year ending March 31, 2024 [Japanese GAAP] (consolidated)
Rohto Pharmaceutical: Confirmation
Rohto Pharmaceutical: Quarterly Report - 88th Term 3rd Quarter (2023/10/01 - 2023/12/31)
Rohto Pharmaceutical: Overview of consolidated financial results for the 3rd quarter (9/1 to 12/31) of the fiscal year ending 2024/3
Rohto Pharmaceutical: Notice regarding revisions to earnings forecasts
Rohto Pharmaceutical: Summary of Financial Results for the 3rd Quarter Ending March 31, 2024 [Japanese GAAP] (Consolidated)
Rohto Pharmaceutical: Confirmation letter
Rohto Pharmaceutical: Quarterly Report - 88th Second Quarter (2023/07/01 - 2023/09/30)
Rohto Pharmaceutical: Results of the 2nd quarter financial results briefing for the fiscal year ending 2024/3
Rohto Pharmaceutical: Rohto Pharmaceutical Co., Ltd. 88th 2nd quarter (fiscal year ending 2023/9) reference materials
Rohto Pharmaceutical: Notice Concerning Revisions to Earnings Forecasts and Dividend Forecasts (Dividend Increase)
Rohto Pharmaceutical: Summary of Financial Results for the 2nd Quarter of the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)
Rohto Pharmaceutical: Confirmation letter
Rohto Pharmaceutical: Quarterly Report - First Quarter of the 88th Period (2023/04/01 - 2023/06/30)
Analysis
Price Target
No Data
